Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study (Q33653575)

28 July 2017

title

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study (English)

1 reference

28 July 2017

1 reference

1 reference

1 reference

ORCID Public Data File 2021

28 July 2017

Bhavana Pothuri

1 reference

author name string

Dennis Yi-Shin Kuo

1 reference

28 July 2017

Stephanie V Blank

1 reference

28 July 2017

Paul J Christos

1 reference

28 July 2017

Mimi Kim

1 reference

28 July 2017

Thomas A Caputo

1 reference

28 July 2017

Dawn Hershman

1 reference

28 July 2017

Noah Goldman

1 reference

28 July 2017

Percy S Ivy

1 reference

28 July 2017

Carolyn D Runowicz

1 reference

28 July 2017

Gary L Goldberg

1 reference

28 July 2017

Mark H Einstein

1 reference

28 July 2017

language of work or name

English

0 references

publication date

20 November 2009

1 reference

28 July 2017

1 reference

28 July 2017

volume

116

1 reference

28 July 2017

1 reference

28 July 2017

page(s)

442-446

1 reference

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

21 June 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Oxaliplatin doublets in non-small cell lung cancer: a literature review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

A systematic review of platinum and taxane resistance from bench to clinic: an inverse relationship

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer: a preliminary phase II study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Ongoing and unsaid on oxaliplatin: the hope

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Chemotherapy for stage IVB or recurrent cancer of the uterine cervix.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Optimal two-stage designs for phase II clinical trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

A phase II study of oxaliplatin and paclitaxel in patients with advanced non-small-cell lung cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2822050

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

30 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.10.082

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.10.082

Chemotherapy for malignant pleural mesothelioma: past results and recent developments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.10.082

Oxaliplatin and paclitaxel combination in patients with platinum-pretreated ovarian carcinoma: An investigator-originated compassionate-use experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.10.082

10.1016/J.YGYNO.2009.10.082

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference